FDA Reminder: De Novos, HDEs Provide Cheaper, Faster Way To Market
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers are selling themselves short by not using the de novo and Humanitarian Device Exemption (HDE) premarket processes more often, FDA's Don St. Pierre maintains